FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2118914286> ?p ?o ?g. }

• W2118914286 endingPage "81" @default.
• W2118914286 startingPage "72" @default.
• W2118914286 abstract "Patients treated with bisphosphonates for osteoporosis may discontinue or require a switch to other therapies. Denosumab binds to RANKL and is a potent inhibitor of bone resorption that has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis. This was a multicenter, international, randomized, double-blind, double-dummy study in 504 postmenopausal women ≥ 55 years of age with a BMD T-score of −2.0 or less and −4.0 or more who had been receiving alendronate therapy for at least 6 months. Subjects received open-label branded alendronate 70 mg once weekly for 1 month and then were randomly assigned to either continued weekly alendronate therapy or subcutaneous denosumab 60 mg every 6 months and were followed for 12 months. Changes in BMD and biochemical markers of bone turnover were evaluated. In subjects transitioning to denosumab, total hip BMD increased by 1.90% at month 12 compared with a 1.05% increase in subjects continuing on alendronate (p < .0001). Significantly greater BMD gains with denosumab compared with alendronate also were achieved at 12 months at the lumbar spine, femoral neck, and 1/3 radius (all p < .0125). Median serum CTX levels remained near baseline in the alendronate group and were significantly decreased versus alendronate (p < .0001) at all time points with denosumab. Adverse events and serious adverse events were balanced between groups. No clinical hypocalcemic adverse events were reported. Transition to denosumab produced greater increases in BMD at all measured skeletal sites and a greater reduction in bone turnover than did continued alendronate with a similar safety profile in both groups. Copyright © 2010 American Society for Bone and Mineral Research" @default.
• W2118914286 created "2016-06-24" @default.
• W2118914286 creator A5010429279 @default.
• W2118914286 creator A5011375575 @default.
• W2118914286 creator A5018289238 @default.
• W2118914286 creator A5032793542 @default.
• W2118914286 creator A5032907896 @default.
• W2118914286 creator A5048640756 @default.
• W2118914286 creator A5060303776 @default.
• W2118914286 creator A5072024974 @default.
• W2118914286 creator A5082366563 @default.
• W2118914286 date "2009-12-14" @default.
• W2118914286 modified "2023-10-14" @default.
• W2118914286 title "Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy" @default.
• W2118914286 cites W1550111394 @default.
• W2118914286 cites W1982069058 @default.
• W2118914286 cites W1984597244 @default.
• W2118914286 cites W1985160737 @default.
• W2118914286 cites W1987169166 @default.
• W2118914286 cites W1988977611 @default.
• W2118914286 cites W1989860636 @default.
• W2118914286 cites W2028721164 @default.
• W2118914286 cites W2029588254 @default.
• W2118914286 cites W2043759393 @default.
• W2118914286 cites W2048299560 @default.
• W2118914286 cites W2048541373 @default.
• W2118914286 cites W2048964656 @default.
• W2118914286 cites W2055940634 @default.
• W2118914286 cites W2057332307 @default.
• W2118914286 cites W2070531118 @default.
• W2118914286 cites W2072508802 @default.
• W2118914286 cites W2096884368 @default.
• W2118914286 cites W2104949625 @default.
• W2118914286 cites W2108258946 @default.
• W2118914286 cites W2110396808 @default.
• W2118914286 cites W2114935509 @default.
• W2118914286 cites W2129577780 @default.
• W2118914286 cites W2133551420 @default.
• W2118914286 cites W2134304734 @default.
• W2118914286 cites W2139996507 @default.
• W2118914286 cites W2152578289 @default.
• W2118914286 cites W2158943274 @default.
• W2118914286 cites W2163058169 @default.
• W2118914286 cites W2167515284 @default.
• W2118914286 cites W2482202957 @default.
• W2118914286 cites W4253861232 @default.
• W2118914286 doi "https://doi.org/10.1359/jbmr.090716" @default.
• W2118914286 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19594293" @default.
• W2118914286 hasPublicationYear "2009" @default.
• W2118914286 type Work @default.
• W2118914286 sameAs 2118914286 @default.
• W2118914286 citedByCount "379" @default.
• W2118914286 countsByYear W21189142862012 @default.
• W2118914286 countsByYear W21189142862013 @default.
• W2118914286 countsByYear W21189142862014 @default.
• W2118914286 countsByYear W21189142862015 @default.
• W2118914286 countsByYear W21189142862016 @default.
• W2118914286 countsByYear W21189142862017 @default.
• W2118914286 countsByYear W21189142862018 @default.
• W2118914286 countsByYear W21189142862019 @default.
• W2118914286 countsByYear W21189142862020 @default.
• W2118914286 countsByYear W21189142862021 @default.
• W2118914286 countsByYear W21189142862022 @default.
• W2118914286 countsByYear W21189142862023 @default.
• W2118914286 crossrefType "journal-article" @default.
• W2118914286 hasAuthorship W2118914286A5010429279 @default.
• W2118914286 hasAuthorship W2118914286A5011375575 @default.
• W2118914286 hasAuthorship W2118914286A5018289238 @default.
• W2118914286 hasAuthorship W2118914286A5032793542 @default.
• W2118914286 hasAuthorship W2118914286A5032907896 @default.
• W2118914286 hasAuthorship W2118914286A5048640756 @default.
• W2118914286 hasAuthorship W2118914286A5060303776 @default.
• W2118914286 hasAuthorship W2118914286A5072024974 @default.
• W2118914286 hasAuthorship W2118914286A5082366563 @default.
• W2118914286 hasBestOaLocation W21189142861 @default.
• W2118914286 hasConcept C126322002 @default.
• W2118914286 hasConcept C126894567 @default.
• W2118914286 hasConcept C170033053 @default.
• W2118914286 hasConcept C197934379 @default.
• W2118914286 hasConcept C2775854910 @default.
• W2118914286 hasConcept C2776286101 @default.
• W2118914286 hasConcept C2776541429 @default.
• W2118914286 hasConcept C2776886416 @default.
• W2118914286 hasConcept C2779809032 @default.
• W2118914286 hasConcept C673006 @default.
• W2118914286 hasConcept C71924100 @default.
• W2118914286 hasConceptScore W2118914286C126322002 @default.
• W2118914286 hasConceptScore W2118914286C126894567 @default.
• W2118914286 hasConceptScore W2118914286C170033053 @default.
• W2118914286 hasConceptScore W2118914286C197934379 @default.
• W2118914286 hasConceptScore W2118914286C2775854910 @default.
• W2118914286 hasConceptScore W2118914286C2776286101 @default.
• W2118914286 hasConceptScore W2118914286C2776541429 @default.
• W2118914286 hasConceptScore W2118914286C2776886416 @default.
• W2118914286 hasConceptScore W2118914286C2779809032 @default.
• W2118914286 hasConceptScore W2118914286C673006 @default.
• W2118914286 hasConceptScore W2118914286C71924100 @default.
• W2118914286 hasIssue "1" @default.

• next